Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
How COVID-19 M&A performed in the pharmaceutical industry in Q3 2024
Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for ten pharmaceutical deals announced in Q3 2024,...
Q3 2024 update: Covid-19 related patent activity in the pharmaceutical industry
The global pharmaceutical industry experienced a 22% decline in the number of Covid-19-related patent applications in Q3 2024 compared with...
Covid-19: the leading companies in COVID recombinant spike proteins revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Covid-19: the leading companies in synthetic COVID vaccines revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Q2 2024 update: mentions of COVID-19 in pharmaceutical industry filings
The global pharmaceutical industry experienced a 75% drop in company filings mentions of COVID-19 in Q2 2024 compared with the...